These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 24668851)
1. Microvilli as markers of disordered apical-membrane trafficking and assembly: bowel and liver. Thompson RJ; Knisely AS Hepatology; 2014 Jul; 60(1):34-6. PubMed ID: 24668851 [No Abstract] [Full Text] [Related]
2. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease. Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397 [TBL] [Abstract][Full Text] [Related]
3. Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis. van IJzendoorn SCD; Li Q; Qiu YL; Wang JS; Overeem AW Hepatology; 2020 Oct; 72(4):1461-1468. PubMed ID: 32583448 [No Abstract] [Full Text] [Related]
4. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806 [TBL] [Abstract][Full Text] [Related]
5. Microvillus inclusion disease with novel MYO5B pathogenic variants. Kwon R; Huang J; Oshima K; Warren M; Voltaggio L; Wang Y; Montgomery EA; Hutchings D Histopathology; 2021 Jul; 79(1):119-121. PubMed ID: 33544913 [No Abstract] [Full Text] [Related]
10. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome. Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677 [TBL] [Abstract][Full Text] [Related]
11. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease. Michaux G; Massey-Harroche D; Nicolle O; Rabant M; Brousse N; Goulet O; Le Bivic A; Ruemmele FM Biol Cell; 2016 Jan; 108(1):19-28. PubMed ID: 26526116 [TBL] [Abstract][Full Text] [Related]
12. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment. Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405 [TBL] [Abstract][Full Text] [Related]
13. Kinetic signatures of myosin-5B, the motor involved in microvillus inclusion disease. Heissler SM; Chinthalapudi K; Sellers JR J Biol Chem; 2017 Nov; 292(44):18372-18385. PubMed ID: 28882893 [TBL] [Abstract][Full Text] [Related]
14. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy. Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597 [TBL] [Abstract][Full Text] [Related]
15. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations. van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347 [TBL] [Abstract][Full Text] [Related]
16. MYO5B Pathogenic Variants Found to Cause Intestinal Symptoms Without Microvillus Inclusion Disease in a Child Who Previously Underwent Liver Transplantation for PFIC-like Cholestasis. Jarasvaraparn C; He M; Granadillo JL; Kulkarni S; Stoll J; Liss K J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):e22-e24. PubMed ID: 32459745 [TBL] [Abstract][Full Text] [Related]
17. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters. Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796 [TBL] [Abstract][Full Text] [Related]
18. Identification of intestinal ion transport defects in microvillus inclusion disease. Kravtsov DV; Ahsan MK; Kumari V; van Ijzendoorn SC; Reyes-Mugica M; Kumar A; Gujral T; Dudeja PK; Ameen NA Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G142-55. PubMed ID: 27229121 [TBL] [Abstract][Full Text] [Related]
19. Toward a cellular model of microvillus inclusion disease. Wilkie AO Hum Mutat; 2010 May; 31(5):v. PubMed ID: 20437611 [No Abstract] [Full Text] [Related]
20. Novel Hassan K; Robay A; Al-Maraghi A; Nimeri N; Azzam AB; Al Shakaki A; Hamid E; Crystal RG; Fakhro KA Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 34815247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]